logo_new@0,5x
  • Glycotest
  • About us
    • Management Team
    • Board of Directors
    • Scientific and Medical Advisors
    • Glycotest Investor Presentation
  • Technology
    • Clinical Data
    • Intellectual Property
  • Investors
  • News
  • Contact us
logo_new@0,75x
logo_new@0,5x
  • Glycotest
  • About us
    • Management Team
    • Board of Directors
    • Scientific and Medical Advisors
    • Glycotest Investor Presentation
  • Technology
    • Clinical Data
    • Intellectual Property
  • Investors
  • News
  • Contact us

Glycotest is developing a new Test for Detecting Early Stage Liver Cancer with the revolutionary approach of using Glycoproteins as Biomarkers – CEOCFO Magazine

September 3, 2019
-
News
-
No comments
-
Posted by Webmaster

Glycotest19-CEOCFOMagazine-Interview.pdf

← PREVIOUS POST
Glycotest, Inc. Receives $3 Million Second Tranche of $10 Million Series A Financing
NEXT POST →
Glycotest was chosen as one of 50 companies to be in the MedTech Showcase in September 2019

Leave a Comment

Your feedback is valuable for us. Your email will not be published.
Cancel Reply

Please wait...
Submit Comment

Related News

Other posts that you should not miss.

Glycotest, Inc. Receives $3 Million Second Tranche of $10 Million Series A Financing

November 21, 2019
-
News

New York, NY—November 21, 2019.  Glycotest, Inc., a diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis–cirrhosis, announced today that the Company …

Read More →
Posted by Webmaster
3 MIN READ

Glycotest was chosen as one of 50 companies to be in the MedTech Showcase in September 2019

August 22, 2019
-
News

MedTech Innovator Showcase Announcement 6.17.19

Read More →
Posted by Webmaster
1 MIN READ

Case-Control Study of the Glycotest™ HCC Panel vs AFP For the Detection of Early-stage Hepatocellular Carcinoma (NCT03878550)

June 13, 2019
-
News
Read More →
Posted by Webmaster
1 MIN READ

GET IN TOUCH

Meet Us

77 Water Street, Suite 817 New York, NY 10005

Give Us A Call

+1 (646) 722-4339

Send Us A Message

info@glycotest.com

Copyright© All Rights Reserved
Website Designed & Developed by Jason and Company
Glycotest is developing a new Test for Detecting Early Stage Liver Cancer with the revolutionary approach of using Glycoproteins as Biomarkers – CEOCFO Magazine | Glycotest Diagnostics